Mark C. Twyman
Corporate Officer/Principal presso INOVIO PHARMACEUTICALS, INC.
Profilo
Mark C.
Twyman is currently the Chief Commercial Officer at Inovio Pharmaceuticals, Inc. He previously held positions as Vice President & General Manager at MedImmune LLC from 2006 to 2008, Vice President-Marketing at Merck & Co., Inc. from 1988 to 2006, Vice President-Marketing at Novavax, Inc. in 2015 and 2016, Senior Vice President & General Manager at Genzyme Corp.
from 2008 to 2011, and Chief Commercial Officer at GI Dynamics, Inc. from 2011 to 2014.
He also worked as Vice President-Marketing at LENSAR, Inc. and Vice President & General Manager-Vaccines at Medimmune, Inc. from 2006 to 2011.
Mr. Twyman received his undergraduate degree from Dickinson College and his MBA from The Wharton School of the University of Pennsylvania.
Posizioni attive di Mark C. Twyman
| Società | Posizione | Inizio |
|---|---|---|
| INOVIO PHARMACEUTICALS, INC. | Corporate Officer/Principal | 15/11/2018 |
Precedenti posizioni note di Mark C. Twyman
| Società | Posizione | Fine |
|---|---|---|
| NOVAVAX, INC. | Sales & Marketing | 01/11/2016 |
| GI DYNAMICS, INC. | Corporate Officer/Principal | 01/07/2014 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2011 |
| Medimmune, Inc. | Corporate Officer/Principal | 01/01/2011 |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 01/01/2008 |
Formazione di Mark C. Twyman
| Dickinson College | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| NOVAVAX, INC. | Health Technology |
| LENSAR, INC. | Health Technology |
| INOVIO PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
GI Dynamics, Inc.
 GI Dynamics, Inc. Medical SpecialtiesHealth Technology GI Dynamics, Inc. engages in the development and commercialization of a medical device system intended for treatment of patients with type 2 diabetes and reduction of obesity. Its pipeline product is EndoBarrier, an endoscopically delivered medical device intended to help restore healthy blood sugar levels and reduce weight. The company was founded by Andy Levine on March 24, 2003 and is headquartered in Boston, MA. | Health Technology |
| Medimmune, Inc. | Health Technology |
- Borsa valori
- Insiders
- Mark C. Twyman
